Pulse Biosciences (PLSE) Income from Continuing Operations (2015 - 2025)
Pulse Biosciences (PLSE) recorded quarterly Income from Continuing Operations of 19366000.0 in Q3 2025, down 1.03% quarter-over-quarter from 19168000.0 in Q2 2025, and down 52.73% on a YoY basis from 40967781.11 in Q3 2024.
Pulse Biosciences (PLSE) Income from Continuing Operations (2015 - 2025) Analysis & Trends
Pulse Biosciences' Income from Continuing Operations history runs 11 years deep, the most recent figure standing at 19366000.0 for Q3 2025.
- In Q3 2025, Income from Continuing Operations fell 52.73% year-over-year to 19366000.0; the TTM figure through Sep 2025 stood at 32471000.0 (up 170.39% YoY), while the FY2025 annual figure was 72800000.0, up 35.82% from the prior year.
- Income from Continuing Operations was 19366000.0 for Q3 2025 at Pulse Biosciences, down from 19168000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 87800000.0 in Q4 2024 to a low of 19366000.0 in Q3 2025.
- Historically, Income from Continuing Operations has averaged 8775526.32 across 5 years, with a median of 13996000.0 in 2022.
- The sharpest annual moves came in 2024 and 2025: Income from Continuing Operations surged 835.77% in 2024, then plunged 68.39% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 15416000.0 in 2021, then surged by 40.34% to 9197000.0 in 2022, then retreated by 29.75% to 11933000.0 in 2023, then soared by 835.77% to 87800000.0 in 2024, then sank by 122.06% to 19366000.0 in 2025.
- The last three Income from Continuing Operations figures came in at 19366000.0 (Q3 2025), 19168000.0 (Q2 2025), and 16795000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 826.00 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -37.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 239.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 398.73 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 135.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 13.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 112.77 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -17.00 Mn |
| 10 | Pulse Biosciences | 1.68 Bn | 1.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -19.37 Mn |
| Jun 30, 2025 | -19.17 Mn |
| Mar 31, 2025 | -16.80 Mn |
| Dec 31, 2024 | 87.80 Mn |
| Sep 30, 2024 | -12.68 Mn |
| Jun 30, 2024 | -11.38 Mn |
| Mar 31, 2024 | -10.14 Mn |
| Dec 31, 2023 | -11.93 Mn |
| Sep 30, 2023 | -10.57 Mn |
| Jun 30, 2023 | -9.91 Mn |
| Mar 31, 2023 | -9.80 Mn |
| Dec 31, 2022 | -9.20 Mn |
| Sep 30, 2022 | -18.04 Mn |
| Jun 30, 2022 | -14.00 Mn |
| Mar 31, 2022 | -17.27 Mn |
| Dec 31, 2021 | -15.42 Mn |
| Sep 30, 2021 | -14.28 Mn |
| Jun 30, 2021 | -15.84 Mn |
| Mar 31, 2021 | -18.75 Mn |
| Dec 31, 2020 | -13.75 Mn |